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1. Introduction 
Haye et al. [ 1,2] have described previously a 
phosphatidylinositol-specific phospholipase A1 in 
thyroid homogenates which is stimulated by thyrot- 
ropin, and have suggested a role for it in the release 
of arachidonic acid for prostaglandin synthesis. They 
did not, however, clearly identify all the products 
formed after PI degradation. The release of free fatty 
acid from PI can also be effected by the combined 
action of PI-phosphodiesterase (EC 3 .1.4.10) and 
diacylglycerol lipase; we have suggested that this latter 
route might be of prime importance in releasing 
arachidonic acid in vivo in a number of physiological 
systems [3-51, and experimental evidence that this 
is so has been obtained in aggregating platelets [6,7]. 
We have, therefore, attempted to repeat the exper- 
iments of Haye et al. [l] using [3H]oleoyl-PI and 
[32P]PI as substrates, both to confirm the thyrot- 
ropin stimulation of fatty acid release, and to identify 
lyso-PI as a product. We have been unsuccessful in 
both attempts: we can find no evidence of an enzy- 
mic activity hydrolysing PI in thyroid homogenates 
other than the PI-phosphodiesterase (with or without 
thyrotropin) and, although the release of free fatty 
acid from [3H]oleoyl-PI is stimulated by thyrotropin, 
addition of the BSA + lactose solution in which the 
hormone is dissolved has an identical stimulatory 
effect. 
2. Materials and methods 
Wherever possible the methods followed were 
Abbreviations: PI, phosphatidylinositol; PC, phosphatidyl- 
choline; BSA, bovine serum albumin 
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those used by Haye et al. [ 11. Thyroid glands were 
taken from pigs killed in this Institute, and homoge- 
nized as in [ 11. Identical results were obtained from 
pigs varying from 1 week to 2 years old. Incubations 
(30 mm) were performed as in [l] (except 2 mg of 
protein per tube was used) with substrates suspended 
as in [ I] at a final concentration of 0.3 mM, and 
fatty acids were extracted according to Dole [8]. 
Before counting of the radioactivity in free fatty acid 
however, the fatty acids were separated from diacyl- 
glycerol by TLC in chloroform/methanol/acetic acid 
(60:50:1 v/v/v); appropriate markers were added and 
made visible by exposure to iodine before scraping 
into 1 ml of methanol in scintillation vials to which 
scintillant was then added. 
For extraction and identification of lyso-PI, the 
extraction method of Bremer was used [9 ] with 
lyso-PI carrier (prepared by the method of [lo]) to 
check the yield and carry over, and also as a marker 
for subsequent separation by TLC in chloroform/ 
methanol/880 ammonia/H,0 (63:35:2:3 by vol.). 
Water-soluble products released from [32P]PI were 
separated by ionophoresis [l I] with appropriate 
markers. 
[32P]PI was prepared as in Irvine et al. [12] and 
[3H]oleoyl-PI and [3H]oleoyl-PC as in Irvine and 
Dawson [5]. 
Thyrotropin was a gift from the National Institute 
of Biological Standards, Holly Hill, Hampstead, 
London, and was dissolved in a serum albumin solu- 
tion as recommended by that Institute. The 20 mg 
tablets contained about 19 mg of lactose, and were 
dissolved in 1% BSA at a concentration of 250 milli- 
units per ml. 
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3. Results and discussion 
Table 1 summarizes the results of a typical exper- 
iment demonstrating the effect of thyrotropin on 
the diacylglycerol and free fatty acid release from 
[3H]oleoyl-PI catalysed by a thyroid homogenate. 
The enzymic activities we observed were very much 
lower than those seen by Haye et al. [l]. These 
authors do not state how much substrate was added 
to their incubations, but if one assumes a protein 
phospholipid ratio of approximately 0.5 for a thyroid 
homogenate, then it is apparent that in their experi- 
ments a quantity of substrate (PC or PI) equal to the 
total thyroid phospholipid added to each tube (about 
0.26 pmol) is hydrolysed within 2 min. We did not 
observe anything within an order of magnitude of this 
activity with either PC or PI substrates (table 1). We 
have not, admittedly used thyroid phospholipids as 
substrates, but as it is clear from Haye et al.‘s data 
[l] that fatty acids other than arachidonate were 
liberated in considerable amounts by thyroid homog 
enates, and as oleic acid is a major 2-acyl fatty acid 
in this tissue [13], it seems unlikely that our use of 
pure [3H]oleoyl-labelled phospholipids would cause 
this difference. 
Another possible contributory factor may be that 
pure PI is very difficult to prepare free of phospha- 
tidylserine, phosphatidylethanolamine or phospha- 
tidic acid, all of which are potent stimulators of the 
PI-phosphodiesterase [141. For the series of experi- 
ments typified by table 1, we added 10% phospha- 
tidic acid and 12% phosphatidylethanolamine to the 
PI substrate to boost the activity; however, very simi- 
Table 1 
Products released from oleoyl PI by a thyroid homogenate 
in 30 minutes 
Free fatty acid Diacylglycerol 
(nmole) (nmole) 
Control 0.88 2.46 
0.44 2.94 
+ Thyrotropin 6.45 8.62 
6.25 9.19 
+ BSA + lactose 6.25 7.30 
6.20 6.61 
Data show duplicate readings from one experiment. Similar 
results were obtained in identical experiment. 12 000 dpm of 
oleoyl Pl were added to each tube. Data are expressed as net 
release of products over tubes in which the homogenate and 
substrate were incubated separately 
288 
lar results to table 1 (with an overall lower level of 
fatty acid and diacylglycerol release) were obtained 
with >99% pure PI (results not shown). Despite these 
quantitative discrepancies with the data of Haye et al. 
[l] it is apparent from table 1 that we have, in prin- 
ciple at least, confirmed their results; a lo-fold stimu- 
lation of free fatty acid release is caused by thyrot- 
repin with no such stimulation for PC (data not 
shown). Table 1 also includes data for tubes to which 
the 1% BSA, 0.3% lactose solution in which the thy- 
rotropin is resuspended was added, and it is apparent 
that the effect of this solution is identical to that of 
thyrotropin. 
Parallel experiments (with both pure PI and with 
PI t phosphatidic acid and phosphatidylethanol- 
amine) were performed using 32P-labelled PI as a sub- 
strate, and we measured the radioactivity in lyso-PI 
and water-soluble inositol esters (no radioactive 
inorganic phosphate was released). We could detect 
no accumulation of radioactivity in 1ysoPI with or 
without thyrotropin, and the only water-soluble 
compound released from PI was phosphoinositol; the 
TCA precipitation technique [ 151 does not permit 
the separation of phosphoinositol from the cyclic 
form [ 161. No glycero-phosphoinositol release could 
be detected even in the presence of a 2 mM glycero- 
phosphoinositol ‘trap’ which, it could be clearly seen, 
was not hydrolysed during the incubation. The 
release of phosphoinositol was stimulated by the 
addition of thyrotropin (or BSA alone). Thus we 
were unable to establish any evidence for deacylation 
of PI with or without thyrotropin, and can only 
assume that the free fatty acid released (table 1) must 
have come from the combined action of PI-phospho- 
diesterase and diacylglycerol lipase. 
A stimulation of PI-phosphodiesterase and diacyl- 
glycerol lipase by BSA could be caused by a variety 
of factors. The latter enzyme is apparently stimulated 
to a greater extent (table l), which may reflect its 
higher requirement for calcium; addition of calcium 
(1 mM) to the tubes reduced (but did not completely 
remove) the BSA stimulation. We observed also that 
the degree of stimulation by BSA depended on the 
dilution of thyroid homogenate in the final incuba- 
ti&: the more dilute the homogenate, the greater the 
stimulation. This, allied with a clear non-linear 
increase in enzyme activity with increasing homoge- 
nate concentration, suggests that BSA is to some 
extent supplying an intrinsic factor (or factors) 
found in the homogenate. Free fatty acid, another 
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component of BSA [ 171 is also stimulatory to the 
PI-phosphodiesterase [141; commercial preparations 
of BSA vary considerably in their fatty acid content 
[ 171 and in fact we found a considerable variation in 
the stimulating effect caused by a series of different 
commercial BSA preparations. Some were indeed 
inhibitors, perhaps a reflection of their differing 
content of lipoprotein, a potent inhibitor of the 
PI-phosphodiesterase [181. We found no evidence in 
our BSA samples of an intrinsic phospholipase activ- 
ity [19]. 
Finally, it is relevant to add here that Haye and 
Jacquemin [20] have also reported a stimulatory 
effect of thyrotropin on the PI-phosphodiesterase 
activity of particle-free thyroid supernatants (assayed 
at pH 5.3 with 0.4 PM Ca”). We have been unable to 
reproduce this stimulation. Some BSA samples (with 
or without thyrotropin) gave a stimulation with no 
added calcium, but none had any effect (or were 
inhibitory) in the presence of calcium. 
In summary, we have not been able to confirm 
exactly quantitatively the results of Haye et al. [l]. 
Although we discuss above several possible contribu- 
tory factors, it is still difficult to account for so large 
a discrepancy in the enzyme activities observed - 
especially with PC as a substrate where many of these 
factors do not apply. We have, however, qualitatively 
confirmed a stimulated release of free fatty acid from 
PI caused by the addition of thyrotropin solutions. In 
our hands this does not appear to be an event medi- 
ated by thyrotropin through its hormonal receptors, 
nor one caused by a stimulationof a phospholipase Aa 
activity. 
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